These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37721964)

  • 21. The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: A cluster randomised trial.
    Hardy M; Samuela J; Kama M; Tuicakau M; Romani L; Whitfeld MJ; King CL; Weil GJ; Grobler AC; Robinson LJ; Kaldor JM; Steer AC
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008106. PubMed ID: 32176703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Country Reports on Practical Aspects of Conducting Large-Scale Community Studies of the Tolerability of Mass Drug Administration with Ivermectin/Diethylcarbamazine/Albendazole for Lymphatic Filariasis.
    Jambulingam P; Subramanian S; Krishnamoorthy K; Supali T; Fischer P; Dubray C; Fayette C; Lemoine JF; Laman M; King C; Samuela J; Hardy M; Weil GJ
    Am J Trop Med Hyg; 2022 May; 106(5_Suppl):18-25. PubMed ID: 35292582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative Safety Surveillance of Triple (IDA) Versus Dual Therapy (DA) in Mass Drug Administration for Elimination of Lymphatic Filariasis in Kenya: A Cohort Event Monitoring Study.
    Khaemba C; Barry A; Omondi WP; Kirui E; Oluka M; Parthasarathi G; Njenga SM; Guantai A; Aklillu E
    Drug Saf; 2023 Oct; 46(10):961-974. PubMed ID: 37552438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized double-blind placebo-controlled field trial of ivermectin and albendazole alone and in combination for the treatment of lymphatic filariasis in Ghana.
    Dunyo SK; Nkrumah FK; Simonsen PE
    Trans R Soc Trop Med Hyg; 2000; 94(2):205-11. PubMed ID: 10897370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The safety of double- and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized study.
    Weil GJ; Bogus J; Christian M; Dubray C; Djuardi Y; Fischer PU; Goss CW; Hardy M; Jambulingam P; King CL; Kuttiat VS; Krishnamoorthy K; Laman M; Lemoine JF; O'Brian KK; Robinson LJ; Samuela J; Schechtman KB; Sircar A; Srividya A; Steer AC; Supali T; Subramanian S;
    PLoS Med; 2019 Jun; 16(6):e1002839. PubMed ID: 31233507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Model-based analysis of trial data: microfilaria and worm-productivity loss after diethylcarbamazine-albendazole or ivermectin-albendazole combination therapy against Wuchereria bancrofti.
    de Kraker ME; Stolk WA; van Oortmarssen GJ; Habbema JD
    Trop Med Int Health; 2006 May; 11(5):718-28. PubMed ID: 16640625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A community survey of coverage and adverse events following country-wide triple-drug mass drug administration for lymphatic filariasis elimination, Samoa 2018.
    Willis GA; Mayfield HJ; Kearns T; Naseri T; Thomsen R; Gass K; Sheridan S; Graves PM; Lau CL
    PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008854. PubMed ID: 33253148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Individual Efficacy and Community Impact of Ivermectin, Diethylcarbamazine, and Albendazole Mass Drug Administration for Lymphatic Filariasis Control in Fiji: A Cluster Randomized Trial.
    Hardy M; Samuela J; Kama M; Tuicakau M; Romani L; Whitfeld MJ; King CL; Weil GJ; Grobler AC; Robinson LJ; Kaldor JM; Steer AC
    Clin Infect Dis; 2021 Sep; 73(6):994-1002. PubMed ID: 33728462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse events following single dose treatment of lymphatic filariasis: Observations from a review of the literature.
    Budge PJ; Herbert C; Andersen BJ; Weil GJ
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006454. PubMed ID: 29768412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
    Horton J; Witt C; Ottesen EA; Lazdins JK; Addiss DG; Awadzi K; Beach MJ; Belizario VY; Dunyo SK; Espinel M; Gyapong JO; Hossain M; Ismail MM; Jayakody RL; Lammie PJ; Makunde W; Richard-Lenoble D; Selve B; Shenoy RK; Simonsen PE; Wamae CN; Weerasooriya MV
    Parasitology; 2000; 121 Suppl():S147-60. PubMed ID: 11386686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term efficacy of single-dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis.
    Ismail MM; Jayakody RL; Weil GJ; Fernando D; De Silva MS; De Silva GA; Balasooriya WK
    Trans R Soc Trop Med Hyg; 2001; 95(3):332-5. PubMed ID: 11491010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tolerability and efficacy of single dose diethylcarbamazine (DEC) alone or co-administration with Ivermectin in the clearance of Wuchereria bancrofti microfilaraemia in Pondicherry, South India.
    Pani SP; Reddy GS; Vanamail P; Venkatesvarlou N; Das LK; Vijayan AP
    J Commun Dis; 2004 Dec; 36(4):240-50. PubMed ID: 16506546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of annual and semi-annual mass drug administration for Lymphatic Filariasis and Onchocerciasis on Hookworm Infection in Côte d'Ivoire.
    Loukouri A; Méité A; Koudou BG; Goss CW; Lew D; Weil GJ; N'Goran EK; Fischer PU
    PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008642. PubMed ID: 32976514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative efficacy of clearing-dose and single high-dose ivermectin and diethylcarbamazine against Wuchereria bancrofti microfilaremia.
    Addiss DG; Eberhard ML; Lammie PJ; McNeeley MB; Lee SH; McNeeley DF; Spencer HC
    Am J Trop Med Hyg; 1993 Feb; 48(2):178-85. PubMed ID: 8447520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Report on active surveillance for adverse events following the use of drug co-administrations in the global programme to eliminate lymphatic filariasis.
    Wkly Epidemiol Rec; 2003 Sep; 78(36):315-7. PubMed ID: 14518107
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of six rounds of single dose mass treatment with diethylcarbamazine or ivermectin on Wuchereria bancrofti infection and its implications for lymphatic filariasis elimination.
    Ramaiah KD; Vanamail P; Pani SP; Yuvaraj J; Das PK
    Trop Med Int Health; 2002 Sep; 7(9):767-74. PubMed ID: 12225508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single versus repeated doses of ivermectin and diethylcarbamazine for the treatment of Wuchereria bancrofti var. pacifica microfilaremia. Results at 12 months of a double-blind study.
    Cartel JL; Spiegel A; Nguyen Ngnoc L; Cardines R; Plichart R; Martin PM; Roux JF
    Trop Med Parasitol; 1991 Dec; 42(4):335-8. PubMed ID: 1796228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of effectiveness of diethylcarbamazine/albendazole combination in reduction of Wuchereria bancrofti infection using multiple infection parameters.
    Wamae CN; Njenga SM; Ngugi BM; Mbui J; Njaanake HK
    Acta Trop; 2011 Sep; 120 Suppl 1():S33-8. PubMed ID: 20933491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Children and adolescents infected with Wuchereria bancrofti in Greater Recife, Brazil: a randomized, year-long clinical trial of single treatments with diethylcarbamazine or diethylcarbamazine-albendazole.
    Rizzo JA; Belo C; Lins R; Dreyer G
    Ann Trop Med Parasitol; 2007 Jul; 101(5):423-33. PubMed ID: 17550648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolonged clearance of microfilaraemia in patients with bancroftian filariasis after multiple high doses of ivermectin or diethylcarbamazine.
    Ismail MM; Weil GJ; Jayasinghe KS; Premaratne UN; Abeyewickreme W; Rajaratnam HN; Sheriff MH; Perera CS; Dissanaike AS
    Trans R Soc Trop Med Hyg; 1996; 90(6):684-8. PubMed ID: 9015519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.